Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs targeted at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where treatment method choices remain limited. Utilize the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Take a look https://financefeeds.com/pu-prime-wins-best-multi-asset-broker-mea-2025-at-ifx-expo-dubai/